LON:AKR Akers Biosciences (AKR) Share Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range 57.50▼ 57.5052-Week Range N/AVolume262 shsAverage Volume818 shsMarket Capitalization£21.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Akers Biosciences alerts: Email Address Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Akers Biosciences Stock (LON:AKR)Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol 'Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company's pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth 'Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.Read More Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. AKR Stock News HeadlinesAugust 20, 2024 | msn.comCam Akers not deterred by Achilles injuries, eyes big role for TexansAugust 3, 2024 | sports.yahoo.comCam Akers talks strong HOF Game performance in RB's first outing since second Achilles injurySeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…July 31, 2024 | msn.comSpringfield Police Superintendent Akers’ employment extended beyond retirement age approved by legislatureJuly 23, 2024 | msn.comAward-Winning Designer Zerina Akers Opens Luxury Fashion Rental Showroom In Los AngelesJuly 23, 2024 | msn.comTexans training camp: RB Cam Akers makes debut in HoustonJuly 22, 2024 | msn.comHouston Texans plan to sign free agent RB Cam Akers to a contractJuly 22, 2024 | msn.comCam Akers won’t be returning to Minnesota after allSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…July 22, 2024 | msn.comHouston Texans sign free agent running back Cam Akers, per reportJuly 22, 2024 | msn.comWhat Cam Akers signing with Texans means for Vikings' RB roomJuly 21, 2024 | msn.comTexans Working Out RB Cam AkersMay 18, 2024 | msn.comCam Akers Possibly Working Toward A ReturnApril 21, 2024 | finance.yahoo.comCan Ackroo Inc. (CVE:AKR) Maintain Its Strong Returns?February 10, 2024 | health.usnews.comMary K. AkersFebruary 9, 2024 | health.usnews.comKristin K. AkersJanuary 23, 2024 | morningstar.comPT AKR Corporindo TbkNovember 6, 2023 | msn.comVikings RB Cam Akers reportedly tore his Achilles in win over FalconsSee More Headlines Receive AKR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryTrading Current SymbolLON:AKR CUSIPN/A CIKN/A Webwww.akersbio.com Phone+1-856-8488698FaxN/AEmployees120Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.44 Quick Ratio2.83 Sales & Book Value Annual Sales£2.32 million Price / Sales9.31 Cash FlowGBX 63.76 per share Price / Cash Flow0.90 Book ValueGBX 65.50 per share Price / Book0.88Miscellaneous Outstanding Shares37,640,000Free FloatN/AMarket Cap£21.64 million OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Gary M. Rauch (Age 63)VP of Fin. & Treasurer Mr. Howard R. Yeaton Jr. (Age 64)CPA, CEO & Interim CFO Mr. Douglas CarraraSr. VP of Global Marketing & Commercial OperationsMs. Pamela E. HiblerVP of Sales & DistributionKey CompetitorsTClarkeLON:CTOValue and Indexed Property IncomeLON:VIPArena Events GroupLON:AREVR EducationLON:VREEnwell Energy plc (RPT.L)LON:RPTView All Competitors AKR Stock Analysis - Frequently Asked Questions How have AKR shares performed this year? Akers Biosciences' stock was trading at GBX 57.50 at the beginning of 2024. Since then, AKR shares have increased by 0.0% and is now trading at GBX 57.50. View the best growth stocks for 2024 here. How do I buy shares of Akers Biosciences? Shares of AKR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Akers Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Akers Biosciences investors own include SandRidge Permian Trust (PER), Rite Aid (RAD), AT&T (T), BP (BP), Cross Timbers Royalty Trust (CRT), Solbright Group (SBRT) and Broadcom (AVGO). This page (LON:AKR) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akers Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.